Use of nebivolol as an anti-atherogenic

Details Use of nebivolol as an anti-atherogenic Use of nebivolol as an anti-atherogenic

A - Human Necessities

61

K

A61K 31/35 (2006.01) A61K 31/353 (2006.01)

Patent

CA 2207333

This invention relates to the use of an .alpha.,.alpha.'- iminobis(methylene)bis[2-chromanmethanol] derivative for the manufacture of a medicament for the therapeutic or prophylactic treatment of humans suffering from or prone to degenerative diseases and conditions of the vascular and nervous system which are associated with oxidative stress.

Cette invention se rapporte à l'utilisation d'un dérivé de alpha , alpha '-iminobis(méthylène)bis[2-chromanméthanol] dans la fabrication d'un médicament destiné au traitement thérapeutique ou profilactique de sujets humains souffrant de maladies et d'états dégénératifs du système vasculaire et nerveux liés au stress oxydant ou de sujets humains prédisposés à ces maladies et états.

Affiliated with

Also associated with

Rating

Use of nebivolol as an anti-atherogenic does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of nebivolol as an anti-atherogenic, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of nebivolol as an anti-atherogenic will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1464128